Media

Supply of unregistered drug Remdesivir for patients with COVID-19

In pursuit of its mission, Glorincor makes the high-tech drug Remdesivir available to thousands of patients. Glorincor signed a state contract in December 2021 for the supply of 162,348 vials of Remdesivir lyophilized powder 100 mg for the healthcare needs of Belarus. Thanks to the policy of the Ministry of Health of the Republic of Belarus, patients receive modern treatment at an affordable price.